Follow Us:

social twitter box white 32 social facebook box blue 32social linkedin box blue 32YoutubeISN Blog

Tuesday, 31 May 2016 10:18

Precision medicine comes of age in nephrology: identification of novel biomarkers and therapeutic targets for chronic kidney disease

By  Wyatt and Schlondorff
Rate this item
(0 votes)

The goal of “precision medicine” is to characterize diseases based on the underlying molecular biology, in order to identify specific biomarkers and therapeutic targets that will ultimately improve clinical outcomes. The nephrology research community has developed a strong foundation for precision medicine, and recent publications demonstrate the feasibility of this approach to identify potential biomarkers and therapeutic targets in chronic kidney disease.

 Authors: Christina M. Wyatt and Detlef Schlondorff

Reference: Kidney Int Volume 89, Issue 4, April 2016, Pages 734-737 ; doi:10.1016/j.kint.2016.02.009

Additional Info

  • Language: English
  • Contains Audio: No
  • Content Type: Articles
  • Source: KI
  • Year: 2016
  • Members Only: No
Read 1706 times Last modified on Tuesday, 31 May 2016 10:51

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact


Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact